Richard J. Lewis
Corporate Officer/Principal bij The University of Queensland
Profiel
Richard J.
Lewis was the founder of Xenome Ltd.
which was founded in 2000, where he held the title of Chief Scientific Officer from 2000 to 2011.
Currently, he holds the title of Principal at The University of Queensland and National Health & Medical Research Council.
In the past, he held the title of Principal at Molecular Pharmacology (USA) Ltd.
Actieve functies van Richard J. Lewis
| Bedrijven | Functie | Begin |
|---|---|---|
| The University of Queensland | Corporate Officer/Principal | 01-07-2009 |
| National Health & Medical Research Council | Corporate Officer/Principal | 01-07-2009 |
Eerdere bekende functies van Richard J. Lewis
| Bedrijven | Functie | Einde |
|---|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Corporate Officer/Principal | - |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
| National Health & Medical Research Council | Government |
